VisiDome is developing an accommodative IOL that offers clear, spectacle-free vision at all distances.
Delivering true accommodative vision – the ability to change focus – to see up close, far away, and everything in between without glasses continues to be the ultimate goal.
VisiDome is developing an accommodative IOL that offers clear, spectacle-free vision at all distances. The Company’s innovative approach is its simple, effective design that efficiently exploits the eyes’ natural accommodating mechanism and overcomes existing flaws of premium lenses.
The VisiDome IOL is an add-on to standard monofocal IOLs and can be implanted during or after cataract surgery.
Founded: October 2013
Stage: Technology development
Investor: The Trendlines Group
IP: Patent applications in the United States and EU (National phase)
Over 20 million people worldwide undergo cataract surgery each year.
The surgery involves removing the eye’s cloudy natural lens and replacing it with an implanted artificial intraocular lens (IOL).
Today’s implanted monofocal IOLs typically provide clear distance vision only, making it difficult to focus on closer objects. As a result, even after undergoing surgery, people require glasses for sharp near and intermediate vision.
Premium multifocal and accommodating IOLs were developed to provide a full range of vision (near, intermediate, distance); yet, existing products do not meet the goal. Patients may still require glasses for reading or using the computer.
The $2.8 billion (2015) global IOL market is forecasted to reach $3.5 billion by 2018, with a CAGR of 6%. The United States is the largest market for IOLs, with revenues forecasted to reach $1.2 billion by 2018. Market leaders include Abbott Medical Optics, Alcon, Bausch and Lomb, Hoya, and Zeiss.
Portable, automatic system for peritoneal dialysis
Device for treating ischemic stroke
Anastomotic closure device for laparoscopic bowel resection
Miniature screwless spine fusion implant
Noninvasive monitoring for the diagnosis of heart failure